Johnson & Johnson (NYSE: JNJ) announced today that it intends to separate its DePuy Synthes Orthopaedics business.
Johnson & Johnson (NYSE: JNJ) announced today that it intends to separate its DePuy Synthes Orthopaedics business.
The company said the separation aims to enhance the strategic and operational focus of each company while driving stakeholder value. It... [4977 chars]